[HTML] from nih.gov…, HE Mansour, SI Ibrahim, IA Hassan - … insights. Arthritis and …, 2011 - ncbi.nlm.nih.gov ... and brucellosis ranked high among the infective causes; whiles lymphomas and leukemia in neoplasm ...Acute pancreatitis in juvenile systemic lupus erythematosus: a manifestation of macrophage activation ... Goto M, Koyama H, Takahashi O, Fukui T. A retrospective review of 226 ...
JA Blake-Haskins, RJ Lechleider… - Clinical Cancer Research, 2011 - AACR ... 34. Lin TS, Stock W, Xu H, Phelps M, Lucas M, Guster S, et al. A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acuteleukemia. Leuk Lymphoma 2009;50:1958–63. 35. ...
M Deng, H Huang, H Jin, O Dirsch… - Investigational new drugs, 2011 - Springer ... 2e, f). Tissue levels in contrast continued to accumulate (Fig. 2g, h). Trough levels after 14 applications on POD 28 were 1.5-fold higher than after one application on POD2 after 70%PH. The accumulation in liver tissue was even more severe after 90% PH. ... Cited by 1 - Related articles - All 5 versions
X Zhang… - Handbook of Practical Immunohistochemistry, 2011 - Springer ... CD7 M Member of Ig superfamily (Chr 17q25.2- 3); marker for T cells Evaluation of T-cell lymphomas (often lost) and acuteleukemia... Positive in acute myeloid leukemia [AML-M1, M2, M3 (35–70%), M4, and M5], HCL, sinus histiocytosis with massive lymphadenopathy ... Related articles - All 2 versions